Literature DB >> 25119058

Can the immunological response to botulinum toxin trigger headaches?

José Fidel Baizabal-Carvallo1.   

Abstract

OnabotulinumtoxinA has recently proved beneficial for the treatment of chronic migraine; even though, headaches are not infrequently reported by patients receiving botulinum toxins for different conditions. Here the author discusses the potential mechanisms on how the immunological response following the application of botulinum toxins may trigger headaches and/or migraine.

Entities:  

Mesh：

Substances：

Year:  2014        PMID： 25119058     DOI： 10.1007/s12640-014-9490-z

Source DB:  PubMed          Journal:  Neurotox Res        ISSN： 1029-8428            Impact factor:   3.911


  6 in total

1.  Local action of the proinflammatory cytokines IL-1β and IL-6 on intracranial meningeal nociceptors.

Authors:  Xichun Zhang; Rami Burstein; Dan Levy
Journal:  Cephalalgia       Date:  2011-12-05       Impact factor: 6.292

2.  Plasma cytokine levels in migraineurs and controls.

Authors:  Francesco Perini; Giovanni D'Andrea; Elisabetta Galloni; Francesco Pignatelli; Giuseppe Billo; Sabrina Alba; Gennaro Bussone; Vito Toso
Journal:  Headache       Date:  2005 Jul-Aug       Impact factor: 5.887

3.  Cerebrospinal fluid cytokine levels in migraine, tension-type headache and cervicogenic headache.

Authors:  S H Bø; E M Davidsen; P Gulbrandsen; E Dietrichs; G Bovim; L J Stovner; L R White
Journal:  Cephalalgia       Date:  2008-10-22       Impact factor: 6.292

4.  Flu-like symptoms and associated immunological response following therapy with botulinum toxins.

Authors:  José Fidel Baizabal-Carvallo; Joseph Jankovic; Jordan Feld
Journal:  Neurotox Res       Date:  2013-05-16       Impact factor: 3.911

5.  IL-1β stimulates COX-2 dependent PGE₂ synthesis and CGRP release in rat trigeminal ganglia cells.

Authors:  Lars Neeb; Peter Hellen; Carsten Boehnke; Jan Hoffmann; Sigrid Schuh-Hofer; Ulrich Dirnagl; Uwe Reuter
Journal:  PLoS One       Date:  2011-03-04       Impact factor: 3.240

6.  Pooled analysis of the safety and tolerability of onabotulinumtoxinA in the treatment of chronic migraine.

Authors:  H-C Diener; D W Dodick; C C Turkel; G Demos; R E Degryse; N L Earl; M F Brin
Journal:  Eur J Neurol       Date:  2014-03-15       Impact factor: 6.089
  6 in total
  1 in total

Review 1.  Therapeutic use of botulinum toxin in pain treatment.

Authors:  Raj Kumar
Journal:  Neuronal Signal       Date:  2018-08-31
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.